Ogen 2.5 Interactions
There are 244 drugs known to interact with Ogen 2.5 (estropipate), along with 17 disease interactions, and 3 alcohol/food interactions. Of the total drug interactions, 27 are major, 198 are moderate, and 19 are minor.
- View all 244 medications that may interact with Ogen 2.5
- View Ogen 2.5 alcohol/food interactions (3)
- View Ogen 2.5 disease interactions (17)
Most frequently checked interactions
View interaction reports for Ogen 2.5 (estropipate) and the medicines listed below.
- Ambien (zolpidem)
- Asmanex Twisthaler (mometasone)
- Atarax (hydroxyzine)
- Benicar (olmesartan)
- biotin
- BuSpar (buspirone)
- Desyrel (trazodone)
- Flax Seed Oil (flax)
- Lipitor (atorvastatin)
- Lumigan (bimatoprost ophthalmic)
- Medrol (methylprednisolone)
- multivitamin
- Nexium (esomeprazole)
- Norco (acetaminophen / hydrocodone)
- Nuvigil (armodafinil)
- Prozac (fluoxetine)
- Salagen (pilocarpine)
- Singulair (montelukast)
- Synthroid (levothyroxine)
- Tegretol (carbamazepine)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Zonegran (zonisamide)
Ogen 2.5 alcohol/food interactions
There are 3 alcohol/food interactions with Ogen 2.5 (estropipate).
Ogen 2.5 disease interactions
There are 17 disease interactions with Ogen 2.5 (estropipate) which include:
- abnormal vaginal bleeding
- carcinomas (estrogenic)
- hypercalcemia in breast cancer
- hypertension
- thromboembolism/cardiovascular
- hepatic neoplasms
- angioedema
- gallbladder disease
- hypercalcemia
- hyperlipidemia
- liver disease
- melasma
- depression
- fluid retention
- glucose intolerance
- retinal thrombosis
- thyroid function tests
More about Ogen 2.5 (estropipate)
- Ogen 2.5 consumer information
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: estrogens
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.